OPDPOregon Prescription Drug Program
OPDPOil Palm Development Programme (India)
OPDPOnline Professional Development Program
OPDPOffice for Personal Data Protection (Czech Republic and Slovakia)
OPDPOgiek People's Development Program (Kenya; est. 1999)
OPDPOfficer Professional Development Programme (Canada)
Copyright 1988-2018 AcronymFinder.com, All rights reserved.
References in periodicals archive ?
A content analysis technique was used to explore the frequency and nature of all warning and untitled letters issued to pharmaceutical companies by the OPDP for advertising and promotional violations over a 12-year period (2005-2016).
We conducted a population-based, repeated cross-sectional study examining quarterly prescription claims for OAB treatments reimbursed by the Ontario Public Drug Programs (OPDP) from January 1, 2000 to June 30, 2016.
It must be pointed out that those with Medicare, Medicaid and health insurance programs pay much less than the OPDP listings, but many people don't have these benefits.
See generally The Office of Prescription Drug Promotion (OPDP), U.S.
The OPDP regulations and guidance documents provide a framework within which the pharmaceutical industry can develop commercial material containing claims that are accurate, balanced, and based on the PI ("on-label") indications.
Keywords: social media; apps; adherence; compliance; safe use; outcomes; OPDP; marketing
Specifically, it is unclear how the FDA conducts surveillance and monitoring of eDTCA (including its sampling methodology for digital advertisements) and how it prioritizes enforcement activities through its Office of Prescription Drug Promotion (OPDP), especially since the OPDP has historically lacked necessary funding to carry out its operational mandates.
Canadian medical claims data from Private Drug Plans (PDP), Regie de l'Assurance Maladie du Quebec (RAMQ), and Ontario Public Drug Plans (OPDP) were analyzed retrospectively.
WASHINGTON -- Although direct-to-consumer advertising has secured significant financial resources from drug companies, pharmaceutical manufacturers (in 2010) actually spent more money advertising to health care professionals than they spent advertising to the public, according to Thomas Abrams, director of the Food and Drug Administration's Office of Prescription Drug Promotion (OPDP) in the Center for Drug Evaluation and Research.
Daniel Kobei, the chairman of the Ogiek Peoples Development Programme (OPDP,) explains: "Major evictions began in parts of the Mau Forest in 1977-- the government did not officially recognise the existence of the Ogiek people, nor did it allow them to be the bona fide owners of their ancestral land".
In a warning letter sent by the FDA, dated October 5, 2018, the FDA's Office of Prescription Drug Promotion said that posts on MannKind Corporation's Facebook page for Afrezza on February 9, 2018, and March 19, 2018 made "false or misleading claims and/or representations about the risks associated with Afrezza by suggesting that there are no safety concerns associated with the use of the drug." The OPDP requested that MannKind immediately cease misbranding Afrezza and/or cease introducing the misbranded drug into interstate commerce and directed the company to submit a written response to its letter on or before October 19, 2018.
In order to regulate drug companies' marketing activities, the usual policy is for the Office of Prescription Drug Promotion (OPDP) within the FDA to send letters to pharmaceutical companies and request that they remove ads or stop unlawful promotional activities if the OPDP alleges that their ads violate the law.